Newbridge Financial Services Group, Inc. Bausch Health Companies Inc. Transaction History

Newbridge Financial Services Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$6.28 - $9.85 $18,840 - $29,550	-3,000 Reduced 69.77%	1,300 $10,000
Q4 2022 Jan 17, 2023	SELL	$6.09 - $7.93 $19,183 - $24,979	-3,150 Reduced 42.28%	4,300 $0
Q3 2022 Oct 13, 2022	SELL	$4.58 - $9.21 $4,580 - $9,210	-1,000 Reduced 11.83%	7,450 $51,000
Q1 2022 Apr 26, 2022	BUY	$21.6 - $27.79 $27,000 - $34,737	1,250 Added 17.36%	8,450 $193,000
Q4 2021 Jan 19, 2022	SELL	$23.0 - $29.01 $25,530 - $32,201	-1,110 Reduced 13.36%	7,200 $199,000

Q3 2021 Oct 27, 2021	BUY	$25.04 - $30.06 $12,770 - $15,330	510 Added 6.54%	8,310 $231,000
Q1 2021 Sep 07, 2021	SELL	$21.37 - $34.38 $25,644 - $41,256	-1,200 Reduced 13.33%	7,800 $248,000
Q4 2020 Sep 07, 2021	SELL	$15.31 - $21.12 $94,003 - $129,676	-6,140 Reduced 40.55%	9,000 $187,000
Q3 2020 Sep 07, 2021	BUY	$14.88 - $20.13 $225,283 - $304,768	15,140 New	15,140 $235,000

262

207M

2.54M

6.46M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.27B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.